ag 1879 has been researched along with Adenocarcinoma in 3 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested the hypotheses that Src tyrosine kinase overactivity represents a chemoresistance mechanism and that Src inhibition may enhance gemcitabine cytotoxicity in pancreatic adenocarcinoma cells." | 7.72 | Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. ( Ashley, SW; Duxbury, MS; Ito, H; Whang, EE; Zinner, MJ, 2004) |
| "We tested the hypotheses that Src tyrosine kinase overactivity represents a chemoresistance mechanism and that Src inhibition may enhance gemcitabine cytotoxicity in pancreatic adenocarcinoma cells." | 3.72 | Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. ( Ashley, SW; Duxbury, MS; Ito, H; Whang, EE; Zinner, MJ, 2004) |
| "Metastasizing colon cancer cells bind target tissues primarily via integrins." | 1.33 | Extracellular pressure stimulates tumor cell adhesion in vitro by paxillin activation. ( Basson, MD; Conway, WC; Craig, DH; Thamilselvan, V; van Zyp, Jv; van Zyp, Nv, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, P | 1 |
| McDaniel, RE | 1 |
| Kim, HR | 1 |
| Clagett, D | 1 |
| Haddad, B | 1 |
| Jordan, VC | 1 |
| Duxbury, MS | 1 |
| Ito, H | 1 |
| Zinner, MJ | 1 |
| Ashley, SW | 1 |
| Whang, EE | 1 |
| van Zyp, Jv | 1 |
| Conway, WC | 1 |
| Craig, DH | 1 |
| van Zyp, Nv | 1 |
| Thamilselvan, V | 1 |
| Basson, MD | 1 |
3 other studies available for ag 1879 and Adenocarcinoma
| Article | Year |
|---|---|
Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Divis | 2012 |
Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting | 2004 |
Extracellular pressure stimulates tumor cell adhesion in vitro by paxillin activation.
Topics: Adenocarcinoma; Animals; Caco-2 Cells; Cell Adhesion; Cell Line, Tumor; Collagen Type I; Colonic Neo | 2006 |